CRISPR 免疫：有理由进行体细胞基因修饰的案例研究？
CRISPR immunity: a case study for justified somatic genetic modification?
机构信息
Medical Science, Brown University, Providence, Rhode Island, USA
Harvard Law School, Cambridge, Massachusetts, USA.
出版信息
J Med Ethics. 2022 Feb;48(2):83-85. doi: 10.1136/medethics-2020-106838. Epub 2021 Mar 3.
The current SARS-CoV-2 pandemic has killed thousands across the world. SARS-CoV-2 is the latest but surely not the last such global pandemic we will face. The biomedical response to such pandemics includes treatment, vaccination, and so on. In this paper, though, we argue that it is time to consider an additional strategy: the somatic (non-heritable) enhancement of human immunity. We argue for this approach and consider bioethics objections we believe can be overcome.
当前的 SARS-CoV-2 大流行已在全球范围内造成数千人死亡。SARS-CoV-2 是最新的，但肯定不是我们将面临的最后一次此类全球大流行。对此类大流行的生物医学应对措施包括治疗、疫苗接种等。然而，在本文中，我们认为是时候考虑另一种策略了：人类免疫力的体细胞（非遗传性）增强。我们主张采用这种方法，并考虑我们认为可以克服的生物伦理学反对意见。
Zotero 插件